Literature DB >> 7856750

Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension.

I Chazova1, J E Loyd, V S Zhdanov, J H Newman, Y Belenkov, B Meyrick.   

Abstract

Primary pulmonary hypertension (PPH) is associated with a spectrum of structural changes in the pulmonary arteries: increased medial thickness, eccentric and concentric intimal thickening, obliteration and recanalization of arteries, and appearance of plexiform and dilatation lesions. The purpose of the present study was to further characterize these structural changes with particular emphasis on arterial adventitial thickness and alterations in the walls of the pulmonary veins. In addition, to determine whether the characteristic structural changes of PPH were size related, each was related to external diameter. With quantitative techniques, the pulmonary vasculature of 19 patients with PPH and 7 controls was examined by light microscopy. In all 19 patients, we found a striking increase in adventitial, as well as intimal and medial, thickness in arteries of all sizes when compared with controls (P < 0.05). In addition, we found intimal and adventitial thickening of pulmonary veins < 250 mu in diameter in approximately half of the PPH cases (P < 0.05). The frequency of arterial obliteration, concentric intimal thickening, and recanalization was 16, 18, and 11 of 19 cases, respectively. These changes were most prevalent in arteries less than 200 mu in diameter whereas eccentric intimal thickening and plexiform lesions occurred in 15 and 6 of the patients, respectively, and were most widespread in arteries > 200 mu. We conclude that remodeling of the pulmonary vasculature in PPH routinely includes thickening of the arterial adventitia and frequently also includes changes in the walls of the pulmonary veins. The finding that recanalization occurs predominantly in the smaller arteries whereas eccentric intimal thickening occurs mainly in the larger ones suggests that recanalization should not be considered a consequence of thromboemboli but may also occur at sites of more fibrotic intimal change.

Entities:  

Mesh:

Year:  1995        PMID: 7856750      PMCID: PMC1869854     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

1.  The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects.

Authors:  D HEATH; J E EDWARDS
Journal:  Circulation       Date:  1958-10       Impact factor: 29.690

2.  Pulmonary veno-occlusive disease.

Authors:  C B Carrington; A A Liebow
Journal:  Hum Pathol       Date:  1970-06       Impact factor: 3.466

3.  Excess collagen in hypertensive pulmonary arteries decreases vascular distensibility.

Authors:  C A Tozzi; D L Christiansen; G J Poiani; D J Riley
Journal:  Am J Respir Crit Care Med       Date:  1994-05       Impact factor: 21.405

4.  An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.

Authors:  B W Christman; C D McPherson; J H Newman; G A King; G R Bernard; B M Groves; J E Loyd
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

5.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; M Yanagisawa; D Langleben; R P Michel; R Levy; H Shennib; S Kimura; T Masaki; W P Duguid; D J Stewart
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

6.  Thrombotic lesions in primary plexogenic arteriopathy. Similar pathogenesis or complication?

Authors:  C A Wagenvoort; P G Mulder
Journal:  Chest       Date:  1993-03       Impact factor: 9.410

7.  Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension.

Authors:  T J Stelzner; R F O'Brien; M Yanagisawa; T Sakurai; K Sato; S Webb; M Zamora; I F McMurtry; J H Fisher
Journal:  Am J Physiol       Date:  1992-05

8.  Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-beta.

Authors:  M D Botney; L Bahadori; L I Gold
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

9.  Pulmonary arteries and veins in experimental hypoxia. An ultrastructural study.

Authors:  K P Dingemans; C A Wagenvoort
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

10.  Hypoxia and incorporation of 3H-thymidine by cells of the rat pulmonary arteries and alveolar wall.

Authors:  B Meyrick; L Reid
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

View more
  38 in total

1.  Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction.

Authors:  Robert F Wideman; Krishna R Hamal
Journal:  J Pharmacol Toxicol Methods       Date:  2011-01-26       Impact factor: 1.950

2.  Pulmonary capillary recruitment in response to hypoxia in healthy humans: a possible role for hypoxic pulmonary venoconstriction?

Authors:  Bryan J Taylor; Jesper Kjaergaard; Eric M Snyder; Thomas P Olson; Bruce D Johnson
Journal:  Respir Physiol Neurobiol       Date:  2011-04-14       Impact factor: 1.931

3.  Modern age pathology of pulmonary arterial hypertension.

Authors:  Elvira Stacher; Brian B Graham; James M Hunt; Aneta Gandjeva; Steve D Groshong; Vallerie V McLaughlin; Marsha Jessup; William E Grizzle; Michaela A Aldred; Carlyne D Cool; Rubin M Tuder
Journal:  Am J Respir Crit Care Med       Date:  2012-06-07       Impact factor: 21.405

4.  Vascular Dysfunction in Pneumocystis-Associated Pulmonary Hypertension Is Related to Endothelin Response and Adrenomedullin Concentration.

Authors:  Dan W Siemsen; Erin Dobrinen; Soo Han; Kari Chiocchi; Nicole Meissner; Steve D Swain
Journal:  Am J Pathol       Date:  2015-12-11       Impact factor: 4.307

Review 5.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

Review 6.  Molecular pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

Review 7.  Molecular pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

Review 8.  Structure and composition of pulmonary arteries, capillaries, and veins.

Authors:  Mary I Townsley
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

9.  Cavitating lung lesions in chronic thromboembolic pulmonary hypertension.

Authors:  Heather Harris; Richard Barraclough; Christine Davies; Iain Armstrong; David G Kiely; Edwin van Beek
Journal:  J Radiol Case Rep       Date:  2008-09-01

Review 10.  Genomics of pulmonary arterial hypertension: implications for therapy.

Authors:  Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.